Dr. William Makis details a framework for cancer treatment using ivermectin and fenbendazole, highlighting a dosage of 1 mg/kg/day, dramatic reported drops in tumor markers, and cases that he believes warrant more extensive clinical studies.
The detailed cancer treatment framework attributed to Dr. William Makis draws renewed attention to a question increasingly accompanying the debate over repurposed drugs: what happens when inexpensive, off-patent medications generate enough laboratory findings, published reports, and clinical cases to justify deeper investigation—yet remain outside the scope of standard oncological protocols?
The material focuses primarily on ivermectin, alongside a separate framework for fenbendazole, with Makis presenting a stepped approach ranging from lower doses to the substantially higher levels discussed in the context of aggressive or metastatic disease.
The figure Makis repeatedly emphasizes is 1 mg/kg/day.
Follow posts by Dr. William Makis on Substack here: https://makisw.substack.com/
Below, you can watch an interview with Dr. William Makis, in which he discusses the use of the aforementioned drugs for treating cancer, including “turbo cancer.”
Source: https://makisw.substack.com/p/ivermectin-articles-and-protocols
